,

Drug Repurposing for Dual Therapeutics Targeting HBV Infection and HCC Development

,

N6-methyladenosine (m6A) RNA methylation regulates hepatitis Delta virus replication

,

AT-9283, a Multi-targeted Kinase Inhibitor, Suppresses the Replication of Hepatitis B Virus and the Development of Hepatocellular Carcinoma

,

Bardoxolone-Methyl (BARD) Suppresses the Replication of Hepatitis B virus and and the development of Hepatocellular Carcinoma via the inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Signaling

,

The role of N6-methyladenosine (m6A) RNA methylation in the Hepatitis B virus life cycle